Patents by Inventor Daniel Golubev

Daniel Golubev has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6471965
    Abstract: A vaccine is disclosed for the prophylaxis against pathogenic development of atherosclerotic plaque in a mammalian subject susceptible thereto which consists essentially of a multiplicity of killed whole-virus strains, selected from the group consisting of: Herpes Simplex Virus 1; Herpes Simplex Virus 2; Herpes Simplex Virus 6; Human Cytomegalovirus; and Epstein-Barr Virus; in combination with a pharmaceutically acceptable inert vaccine carrier or diluent.
    Type: Grant
    Filed: July 27, 1994
    Date of Patent: October 29, 2002
    Assignee: Bio-Virus Research Incorporated
    Inventors: Daniel Golubev, Alexander Chaihorsky
  • Patent number: 5837262
    Abstract: A pharmaceutical composition is disclosed for the treatment against several herpes virus infections or atherosclerotic plaques in a mammalian subject suspectible thereto which comprises: (a) 10 to 30% by weight of the peptide of SEQ ID 2; (b) 10 to 30% by weight of the peptide of SEQ ID 4; 10 to 30% by weight of the peptide of SEQ ID 6; and (d) 10 to 30% by weight of the peptide of SEQ ID 8; in combination with a pharmaceutically acceptable inert carrier.
    Type: Grant
    Filed: March 20, 1996
    Date of Patent: November 17, 1998
    Assignee: Bio-Virus Research Incorporated
    Inventors: Daniel Golubev, Alexander Chaihorsky